Collegium executes $35M accelerated share repurchase with Jefferies; initial 888,889 shares delivered

COLLEGIUM PHARMACEUTICAL, INC

ASR agreement under $150M buyback program authorized in Jan 2024; $35M paid to Jefferies.
Initial delivery of 888,889 shares based on $31.50 closing price on May 10, 2024 (~80% of expected total).
Final number determined by VWAP during ASR term; settlement expected Q3 2024.
As of March 31, 2024, outstanding shares ~32.7M, implying initial delivery covers ~2.7% of shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.